BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24015775)

  • 21. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.
    Becker M; Kramann R; Franke A; Breithardt OA; Heussen N; Knackstedt C; Stellbrink C; Schauerte P; Kelm M; Hoffmann R
    Eur Heart J; 2007 May; 28(10):1211-20. PubMed ID: 17426079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
    Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular wall motion analysis to guide management of CRT non-responders.
    Nitsche B; Eitel C; Bode K; Wetzel U; Richter S; Döring M; Hindricks G; Piorkowski C; Gaspar T
    Europace; 2015 May; 17(5):778-86. PubMed ID: 25825461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy.
    Kydd AC; Khan FZ; Ring L; Pugh PJ; Virdee MS; Dutka DP
    Eur J Heart Fail; 2014 Nov; 16(11):1206-13. PubMed ID: 25302484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy.
    Gorcsan J; Tanabe M; Bleeker GB; Suffoletto MS; Thomas NC; Saba S; Tops LF; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2007 Oct; 50(15):1476-83. PubMed ID: 17919568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy.
    Stankovic I; Aarones M; Smith HJ; Vörös G; Kongsgaard E; Neskovic AN; Willems R; Aakhus S; Voigt JU
    Eur Heart J; 2014 Jan; 35(1):48-55. PubMed ID: 23918757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study.
    Biffi M; Defaye P; Jaïs P; Ruffa F; Leclercq C; Gras D; Yang Z; Gerritse B; Ziacchi M; Morgan JM;
    Int J Cardiol; 2018 May; 259():88-93. PubMed ID: 29579617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Male gender and chronic obstructive pulmonary disease predict a poor clinical response in patients undergoing cardiac resynchronisation therapy.
    Kirubakaran S; Ladwiniec A; Arujuna A; Ginks M; McPhail M; Bostock J; Carr-White G; Rinaldi CA
    Int J Clin Pract; 2011 Mar; 65(3):281-8. PubMed ID: 21314865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The right ventricular septum presents the optimum site for maximal electrical separation during left ventricular pacing.
    Miranda RI; Nault M; Simpson CS; Michael KA; Abdollah H; Baranchuk A; Redfearn DP
    J Cardiovasc Electrophysiol; 2012 Apr; 23(4):370-4. PubMed ID: 22049976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of response to cardiac resynchronization therapy--importance of left ventricular dyssynchrony.
    Santos JF; Parreira L; Madeira J; Seixo F; Mendes L; Lopes C; Venâncio J; Lourenço J; Caetano F; Inês L; Mendes M
    Rev Port Cardiol; 2006 Jun; 25(6):569-81. PubMed ID: 17019976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure.
    Pires LA; Ghio S; Chung ES; Tavazzi L; Abraham WT; Gerritse B
    Congest Heart Fail; 2011; 17(2):65-70. PubMed ID: 21449994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measures of left ventricular dyssynchrony and the correlation to clinical and echocardiographic response after cardiac resynchronization therapy.
    Abdelhadi R; Adelstein E; Voigt A; Gorcsan J; Saba S
    Am J Cardiol; 2008 Sep; 102(5):598-601. PubMed ID: 18721519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of overlapping of the E and A waves of the transmitral flow as a predictor of responders to cardiac resynchronization therapy.
    Minamiguchi H; Sakata Y; Ohtani T; Mizote I; Takeda Y; Mizuno H; Okuyama Y; Nakatani S; Fujita M; Watanabe T; Uematsu M; Komuro I
    Am J Cardiol; 2013 Jun; 111(11):1613-8. PubMed ID: 23497774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization.
    Becker M; Hoffmann R; Schmitz F; Hundemer A; Kühl H; Schauerte P; Kelm M; Franke A
    Am J Cardiol; 2007 Dec; 100(11):1671-6. PubMed ID: 18036367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.